A detailed history of Allworth Financial LP transactions in Myriad Genetics Inc stock. As of the latest transaction made, Allworth Financial LP holds 15 shares of MYGN stock, worth $263. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 15 -0.0%
Holding current value
$263
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 24, 2024

SELL
$13.91 - $21.32 $528 - $810
-38 Reduced 71.7%
15 $0
Q3 2023

Oct 31, 2023

BUY
$15.99 - $23.22 $847 - $1,230
53 New
53 $0
Q2 2022

Jul 13, 2022

SELL
$16.45 - $25.88 $148 - $232
-9 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$22.67 - $28.01 $204 - $252
9 New
9 $0

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.42B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.